FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brian Slingsby

Research Profile

Concepts & Ideas

Chemicals & Drugs

Genes & Molecular Sequences

Molecular Structure

Co-author Network

Publications

TOP 3
Gerard M P Giblin; Celestine T O'Shaughnessy; Alan Naylor; William L Mitchell; Andrew J Eatherton; Brian P Slingsby; D Anthony Rawlings; Paul Goldsmith; Andrew J Brown; Claudine Haslam; Nicholas M Clayton; Alex W Wilson; Iain P Chessell; Andrew R Wittington; Richard Green
Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain.
Jason Witherington; Vincent Bordas; Alessandra Gaiba; Alan Naylor; Anthony D Rawlings; Brian P Slingsby; David G Smith; Andrew K Takle; Robert W Ward
6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).
Jason Witherington; Vincent Bordas; Alessandra Gaiba; Neil S Garton; Alan Naylor; Anthony D Rawlings; Brian P Slingsby; David G Smith; Andrew K Takle; Robert W Ward
6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brian Slingsby (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Gerard M P Giblin; Celestine T O'Shaughnessy; Alan Naylor; William L Mitchell; Andrew J Eatherton; Brian P Slingsby; D Anthony Rawlings; Paul Goldsmith; Andrew J Brown; Claudine Haslam; Nicholas M Clayton; Alex W Wilson; Iain P Chessell; Andrew R Wittington; Richard Green
Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain.
Journal of medicinal chemistry 2007;50(11):2597-600.
2003: Jason Witherington; Vincent Bordas; Alessandra Gaiba; Alan Naylor; Anthony D Rawlings; Brian P Slingsby; David G Smith; Andrew K Takle; Robert W Ward
6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).
Bioorganic & medicinal chemistry letters 2003;13(18):3059-62.
2003: Jason Witherington; Vincent Bordas; Alessandra Gaiba; Neil S Garton; Alan Naylor; Anthony D Rawlings; Brian P Slingsby; David G Smith; Andrew K Takle; Robert W Ward
6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).
Bioorganic & medicinal chemistry letters 2003;13(18):3055-7.
2003: Jason Witherington; Vincent Bordas; David Haigh; Deirdre M B Hickey; Robert J Ife; Anthony D Rawlings; Brian P Slingsby; David G Smith; Robert W Ward
5-aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).
Bioorganic & medicinal chemistry letters 2003;13(9):1581-4.
2001: David G Smith; M Buffet; AE Fenwick; David Haigh; Robert J Ife; M Saunders; Brian P Slingsby; RC Stacey; Robert W Ward
3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).
Bioorganic & medicinal chemistry letters 2001;11(5):635-9.
2000: Helen F Boyd; S T Flynn; Deirdre M B Hickey; Robert J Ife; M Jones; Colin A Leach; Colin H Macphee; Kevin J Milliner; D Anthony Rawlings; Brian P Slingsby; Stephen A Smith; Ian G Stansfield; David Tew; Colin J Theobald
2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2.
Bioorganic & medicinal chemistry letters 2000;10(4):395-8.
1999: David G Smith; Andrew D Gribble; David Haigh; Robert J Ife; P Lavery; P Skett; Brian P Slingsby; RC Stacey; Robert W Ward; Andrew West
The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.
Bioorganic & medicinal chemistry letters 1999;9(21):3137-42.